Found 98 hits with Last Name = 'sanchez' and Initial = 'b' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215294
(2-(N-(6-chloro-7-methyl-2,3-dioxo-1,2,3,4-tetrahyd...)Show SMILES Cc1cc2[nH]c(=O)c(=O)[nH]c2c(N(CC(O)=O)S(C)(=O)=O)c1Cl Show InChI InChI=1S/C12H12ClN3O6S/c1-5-3-6-9(15-12(20)11(19)14-6)10(8(5)13)16(4-7(17)18)23(2,21)22/h3H,4H2,1-2H3,(H,14,19)(H,15,20)(H,17,18) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D
(Homo sapiens (Human)) | BDBM50491647
(CHEMBL2387019)Show SMILES CCC(CC)c1nn(CC)c2c1N=C(CNC2=O)c1ccc(cc1)C(O)=O |c:13| Show InChI InChI=1S/C20H24N4O3/c1-4-12(5-2)16-17-18(24(6-3)23-16)19(25)21-11-15(22-17)13-7-9-14(10-8-13)20(26)27/h7-10,12H,4-6,11H2,1-3H3,(H,21,25)(H,26,27) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491689
(CHEMBL2387425)Show SMILES COc1ccc(cc1-c1cnc(nc1)N1CCCC1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:22| Show InChI InChI=1S/C27H33N7O3/c1-27(2,3)24-22-23(34(32-24)11-12-35)25(36)28-16-20(31-22)17-7-8-21(37-4)19(13-17)18-14-29-26(30-15-18)33-9-5-6-10-33/h7-8,13-15,35H,5-6,9-12,16H2,1-4H3,(H,28,36) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491682
(CHEMBL2387423)Show SMILES COc1ccc(cc1-c1cnc(cc1C)N(C)C)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C27H34N6O3/c1-16-12-22(32(5)6)28-14-19(16)18-13-17(8-9-21(18)36-7)20-15-29-26(35)24-23(30-20)25(27(2,3)4)31-33(24)10-11-34/h8-9,12-14,34H,10-11,15H2,1-7H3,(H,29,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491698
(CHEMBL2387426)Show SMILES COc1ccc(cc1-c1cnc(nc1)N1CCOCC1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:23| Show InChI InChI=1S/C27H33N7O4/c1-27(2,3)24-22-23(34(32-24)7-10-35)25(36)28-16-20(31-22)17-5-6-21(37-4)19(13-17)18-14-29-26(30-15-18)33-8-11-38-12-9-33/h5-6,13-15,35H,7-12,16H2,1-4H3,(H,28,36) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491681
(CHEMBL2387427)Show SMILES COc1ccc(c(OC)n1)-c1cc(ccc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C26H31N5O5/c1-26(2,3)23-21-22(31(30-23)11-12-32)24(33)27-14-18(28-21)15-7-9-19(34-4)17(13-15)16-8-10-20(35-5)29-25(16)36-6/h7-10,13,32H,11-12,14H2,1-6H3,(H,27,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215284
(2-(N-(7-chloro-6-methyl-2,3-dioxo-1,2,3,4-tetrahyd...)Show SMILES Cc1c(Cl)cc2[nH]c(=O)c(=O)[nH]c2c1N(CC(O)=O)S(C)(=O)=O Show InChI InChI=1S/C12H12ClN3O6S/c1-5-6(13)3-7-9(15-12(20)11(19)14-7)10(5)16(4-8(17)18)23(2,21)22/h3H,4H2,1-2H3,(H,14,19)(H,15,20)(H,17,18) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215283
(2-(N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroqui...)Show SMILES CS(=O)(=O)N(CC(O)=O)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C11H9Cl2N3O6S/c1-23(21,22)16(3-6(17)18)9-7(13)4(12)2-5-8(9)15-11(20)10(19)14-5/h2H,3H2,1H3,(H,14,19)(H,15,20)(H,17,18) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491680
(CHEMBL2387429)Show SMILES COc1ccc(cc1-c1cnc(nc1)N1CCCCC1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:23| Show InChI InChI=1S/C28H35N7O3/c1-28(2,3)25-23-24(35(33-25)12-13-36)26(37)29-17-21(32-23)18-8-9-22(38-4)20(14-18)19-15-30-27(31-16-19)34-10-6-5-7-11-34/h8-9,14-16,36H,5-7,10-13,17H2,1-4H3,(H,29,37) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491693
(CHEMBL2387428)Show SMILES COc1ccc(cc1-c1cnc(nc1)N(C)C)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:19| Show InChI InChI=1S/C25H31N7O3/c1-25(2,3)22-20-21(32(30-22)9-10-33)23(34)26-14-18(29-20)15-7-8-19(35-6)17(11-15)16-12-27-24(28-13-16)31(4)5/h7-8,11-13,33H,9-10,14H2,1-6H3,(H,26,34) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491679
(CHEMBL2387430 | US11419874, Example 3)Show SMILES COc1ccc(cc1-c1cnc(OC)nc1)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:18| Show InChI InChI=1S/C24H28N6O4/c1-24(2,3)21-19-20(30(29-21)8-9-31)22(32)25-13-17(28-19)14-6-7-18(33-4)16(10-14)15-11-26-23(34-5)27-12-15/h6-7,10-12,31H,8-9,13H2,1-5H3,(H,25,32) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491694
(CHEMBL2385104)Show SMILES COc1ccc(c(OC)c1)-c1cc(ccc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C27H32N4O5/c1-27(2,3)25-23-24(31(30-25)11-12-32)26(33)28-15-20(29-23)16-7-10-21(35-5)19(13-16)18-9-8-17(34-4)14-22(18)36-6/h7-10,13-14,32H,11-12,15H2,1-6H3,(H,28,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215282
(CHEMBL429296 | N-(6-chloro-7-methyl-2,3-dioxo-1,2,...)Show SMILES Cc1cc2[nH]c(=O)c(=O)[nH]c2c(N(CCO)S(C)(=O)=O)c1Cl Show InChI InChI=1S/C12H14ClN3O5S/c1-6-5-7-9(15-12(19)11(18)14-7)10(8(6)13)16(3-4-17)22(2,20)21/h5,17H,3-4H2,1-2H3,(H,14,18)(H,15,19) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491651
(CHEMBL2387143)Show SMILES COc1ccc(Cc2nn3c(nc(C)c3c(=O)[nH]2)[C@@H](CCc2ccccc2)[C@@H](C)O)cc1OO |r| Show InChI InChI=1S/C25H28N4O5/c1-15-23-25(31)27-22(14-18-10-12-20(33-3)21(13-18)34-32)28-29(23)24(26-15)19(16(2)30)11-9-17-7-5-4-6-8-17/h4-8,10,12-13,16,19,30,32H,9,11,14H2,1-3H3,(H,27,28,31)/t16-,19+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| KEGG PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491699
(CHEMBL2387422)Show SMILES COc1ccc(cc1-c1cnn(C)c1)C1=Nc2c(C(=O)NC1)n(CCO)nc2C(C)(C)C |t:16| Show InChI InChI=1S/C23H28N6O3/c1-23(2,3)21-19-20(29(27-21)8-9-30)22(31)24-12-17(26-19)14-6-7-18(32-5)16(10-14)15-11-25-28(4)13-15/h6-7,10-11,13,30H,8-9,12H2,1-5H3,(H,24,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491690
(CHEMBL2387441)Show SMILES COc1ccc(cc1-c1cnc(OC)nc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C26H32N6O5/c1-26(2,3)22-20-21(32(31-22)10-7-11-33)23(34)27-14-18(29-20)15-8-9-19(35-4)16(12-15)17-13-28-25(37-6)30-24(17)36-5/h8-9,12-13,33H,7,10-11,14H2,1-6H3,(H,27,34) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215286
(CHEMBL399275 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES COCCCN(c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O Show InChI InChI=1S/C13H15Cl2N3O5S/c1-23-5-3-4-18(24(2,21)22)11-9(15)7(14)6-8-10(11)17-13(20)12(19)16-8/h6H,3-5H2,1-2H3,(H,16,19)(H,17,20) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215286
(CHEMBL399275 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES COCCCN(c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O Show InChI InChI=1S/C13H15Cl2N3O5S/c1-23-5-3-4-18(24(2,21)22)11-9(15)7(14)6-8-10(11)17-13(20)12(19)16-8/h6H,3-5H2,1-2H3,(H,16,19)(H,17,20) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491697
(CHEMBL2387424)Show SMILES COc1ccc(cc1-c1cnc(OC)nc1OC)C1=Nc2c(nn(CCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C25H30N6O5/c1-25(2,3)21-19-20(31(30-21)9-10-32)22(33)26-13-17(28-19)14-7-8-18(34-4)15(11-14)16-12-27-24(36-6)29-23(16)35-5/h7-8,11-12,32H,9-10,13H2,1-6H3,(H,26,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 9.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215281
(CHEMBL248443 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CS(=O)(=O)N(CCC(F)(F)F)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C12H10Cl2F3N3O4S/c1-25(23,24)20(3-2-12(15,16)17)9-7(14)5(13)4-6-8(9)19-11(22)10(21)18-6/h4H,2-3H2,1H3,(H,18,21)(H,19,22) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215287
(CHEMBL247035 | N-(3-methoxybenzyl)-N-(6,7-dichloro...)Show SMILES COc1cccc(CN(c2c(Cl)c(Cl)cc3[nH]c(=O)c(=O)[nH]c23)S(C)(=O)=O)c1 Show InChI InChI=1S/C17H15Cl2N3O5S/c1-27-10-5-3-4-9(6-10)8-22(28(2,25)26)15-13(19)11(18)7-12-14(15)21-17(24)16(23)20-12/h3-7H,8H2,1-2H3,(H,20,23)(H,21,24) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491692
(CHEMBL2387436)Show SMILES COc1ccc(c(OC)c1)-c1cc(ccc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C28H34N4O5/c1-28(2,3)26-24-25(32(31-26)12-7-13-33)27(34)29-16-21(30-24)17-8-11-22(36-5)20(14-17)19-10-9-18(35-4)15-23(19)37-6/h8-11,14-15,33H,7,12-13,16H2,1-6H3,(H,29,34) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215296
(CHEMBL401849 | N-(7-chloro-6-methyl-2,3-dioxo-1,2,...)Show SMILES Cc1c(Cl)cc2[nH]c(=O)c(=O)[nH]c2c1N(CCO)S(C)(=O)=O Show InChI InChI=1S/C12H14ClN3O5S/c1-6-7(13)5-8-9(15-12(19)11(18)14-8)10(6)16(3-4-17)22(2,20)21/h5,17H,3-4H2,1-2H3,(H,14,18)(H,15,19) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491683
(CHEMBL2387440)Show SMILES COc1ccc(cc1-c1cnc(cc1C)N(C)C)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C28H36N6O3/c1-17-13-23(33(5)6)29-15-20(17)19-14-18(9-10-22(19)37-7)21-16-30-27(36)25-24(31-21)26(28(2,3)4)32-34(25)11-8-12-35/h9-10,13-15,35H,8,11-12,16H2,1-7H3,(H,30,36) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215285
(CHEMBL400508 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CCOCCCN(c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O Show InChI InChI=1S/C14H17Cl2N3O5S/c1-3-24-6-4-5-19(25(2,22)23)12-10(16)8(15)7-9-11(12)18-14(21)13(20)17-9/h7H,3-6H2,1-2H3,(H,17,20)(H,18,21) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215276
(CHEMBL399519 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CCS(=O)(=O)N(CCC(F)(F)F)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C13H12Cl2F3N3O4S/c1-2-26(24,25)21(4-3-13(16,17)18)10-8(15)6(14)5-7-9(10)20-12(23)11(22)19-7/h5H,2-4H2,1H3,(H,19,22)(H,20,23) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215281
(CHEMBL248443 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CS(=O)(=O)N(CCC(F)(F)F)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C12H10Cl2F3N3O4S/c1-25(23,24)20(3-2-12(15,16)17)9-7(14)5(13)4-6-8(9)19-11(22)10(21)18-6/h4H,2-3H2,1H3,(H,18,21)(H,19,22) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215281
(CHEMBL248443 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CS(=O)(=O)N(CCC(F)(F)F)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C12H10Cl2F3N3O4S/c1-25(23,24)20(3-2-12(15,16)17)9-7(14)5(13)4-6-8(9)19-11(22)10(21)18-6/h4H,2-3H2,1H3,(H,18,21)(H,19,22) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491645
(CHEMBL2387135)Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(OC)c(OC)c1 |c:14| Show InChI InChI=1S/C21H28N4O4/c1-5-13(6-2)18-19-20(25(24-18)9-10-26)21(27)22-12-15(23-19)14-7-8-16(28-3)17(11-14)29-4/h7-8,11,13,26H,5-6,9-10,12H2,1-4H3,(H,22,27) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D
(Homo sapiens (Human)) | BDBM50491650
(CHEMBL2387020)Show SMILES CC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(F)cc1 |c:13| Show InChI InChI=1S/C18H21FN4O2/c1-18(2,3)16-14-15(23(22-16)8-9-24)17(25)20-10-13(21-14)11-4-6-12(19)7-5-11/h4-7,24H,8-10H2,1-3H3,(H,20,25) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491684
(CHEMBL2387439)Show SMILES COc1ccc(cc1-c1cnn(C)c1)C1=Nc2c(C(=O)NC1)n(CCCO)nc2C(C)(C)C |t:16| Show InChI InChI=1S/C24H30N6O3/c1-24(2,3)22-20-21(30(28-22)9-6-10-31)23(32)25-13-18(27-20)15-7-8-19(33-5)17(11-15)16-12-26-29(4)14-16/h7-8,11-12,14,31H,6,9-10,13H2,1-5H3,(H,25,32) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215279
(CHEMBL248439 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES COCCN(c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O Show InChI InChI=1S/C12H13Cl2N3O5S/c1-22-4-3-17(23(2,20)21)10-8(14)6(13)5-7-9(10)16-12(19)11(18)15-7/h5H,3-4H2,1-2H3,(H,15,18)(H,16,19) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215298
(CHEMBL399075 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CS(=O)(=O)N(CC1CCCCO1)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 |w:6.5| Show InChI InChI=1S/C15H17Cl2N3O5S/c1-26(23,24)20(7-8-4-2-3-5-25-8)13-11(17)9(16)6-10-12(13)19-15(22)14(21)18-10/h6,8H,2-5,7H2,1H3,(H,18,21)(H,19,22) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491695
(CHEMBL2387437)Show SMILES COc1ccc(cc1-c1ccc(cc1)C(O)=O)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:19| Show InChI InChI=1S/C27H30N4O5/c1-27(2,3)24-22-23(31(30-24)12-5-13-32)25(33)28-15-20(29-22)18-10-11-21(36-4)19(14-18)16-6-8-17(9-7-16)26(34)35/h6-11,14,32H,5,12-13,15H2,1-4H3,(H,28,33)(H,34,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215297
(CHEMBL247034 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CC(O)CN(c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O |w:1.0| Show InChI InChI=1S/C12H13Cl2N3O5S/c1-5(18)4-17(23(2,21)22)10-8(14)6(13)3-7-9(10)16-12(20)11(19)15-7/h3,5,18H,4H2,1-2H3,(H,15,19)(H,16,20) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215292
(CHEMBL401100 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CS(=O)(=O)N(CCCO)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C12H13Cl2N3O5S/c1-23(21,22)17(3-2-4-18)10-8(14)6(13)5-7-9(10)16-12(20)11(19)15-7/h5,18H,2-4H2,1H3,(H,15,19)(H,16,20) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491644
(CHEMBL2387139)Show SMILES CCC(CC)c1nn(CCCO)c2c1N=C(CNC2=O)c1ccccc1 |c:15| Show InChI InChI=1S/C20H26N4O2/c1-3-14(4-2)17-18-19(24(23-17)11-8-12-25)20(26)21-13-16(22-18)15-9-6-5-7-10-15/h5-7,9-10,14,25H,3-4,8,11-13H2,1-2H3,(H,21,26) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491643
(CHEMBL2387140)Show SMILES CCC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1ccnc1C |c:14| Show InChI InChI=1S/C23H28N6O2/c1-5-23(3,4)21-19-20(29(27-21)12-13-30)22(31)25-14-18(26-19)16-6-8-17(9-7-16)28-11-10-24-15(28)2/h6-11,30H,5,12-14H2,1-4H3,(H,25,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215280
(CHEMBL248436 | N-(3-fluorobenzyl)-N-(6,7-dichloro-...)Show SMILES CS(=O)(=O)N(Cc1cccc(F)c1)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 Show InChI InChI=1S/C16H12Cl2FN3O4S/c1-27(25,26)22(7-8-3-2-4-9(19)5-8)14-12(18)10(17)6-11-13(14)21-16(24)15(23)20-11/h2-6H,7H2,1H3,(H,20,23)(H,21,24) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491643
(CHEMBL2387140)Show SMILES CCC(C)(C)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1ccnc1C |c:14| Show InChI InChI=1S/C23H28N6O2/c1-5-23(3,4)21-19-20(29(27-21)12-13-30)22(31)25-14-18(26-19)16-6-8-17(9-7-16)28-11-10-24-15(28)2/h6-11,30H,5,12-14H2,1-4H3,(H,25,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491685
(CHEMBL2387435)Show SMILES COc1ccc(OC)c(c1)-c1cc(ccc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:20| Show InChI InChI=1S/C28H34N4O5/c1-28(2,3)26-24-25(32(31-26)12-7-13-33)27(34)29-16-21(30-24)17-8-10-22(36-5)19(14-17)20-15-18(35-4)9-11-23(20)37-6/h8-11,14-15,33H,7,12-13,16H2,1-6H3,(H,29,34) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D
(Homo sapiens (Human)) | BDBM50491645
(CHEMBL2387135)Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(OC)c(OC)c1 |c:14| Show InChI InChI=1S/C21H28N4O4/c1-5-13(6-2)18-19-20(25(24-18)9-10-26)21(27)22-12-15(23-19)14-7-8-16(28-3)17(11-14)29-4/h7-8,11,13,26H,5-6,9-10,12H2,1-4H3,(H,22,27) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215278
(CHEMBL248446 | N-(6-chloro-7-ethyl-2,3-dioxo-1,2,3...)Show SMILES CCc1cc2[nH]c(=O)c(=O)[nH]c2c(N(CCCOC)S(C)(=O)=O)c1Cl Show InChI InChI=1S/C15H20ClN3O5S/c1-4-9-8-10-12(18-15(21)14(20)17-10)13(11(9)16)19(25(3,22)23)6-5-7-24-2/h8H,4-7H2,1-3H3,(H,17,20)(H,18,21) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491646
(CHEMBL2387021)Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccc(cc1)-n1ccnc1C |c:14| Show InChI InChI=1S/C23H28N6O2/c1-4-16(5-2)20-21-22(29(27-20)12-13-30)23(31)25-14-19(26-21)17-6-8-18(9-7-17)28-11-10-24-15(28)3/h6-11,16,30H,4-5,12-14H2,1-3H3,(H,25,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215277
(CHEMBL401253 | N-(7-chloro-6-ethyl-2,3-dioxo-1,2,3...)Show SMILES CCc1c(Cl)cc2[nH]c(=O)c(=O)[nH]c2c1N(CCO)S(C)(=O)=O Show InChI InChI=1S/C13H16ClN3O5S/c1-3-7-8(14)6-9-10(16-13(20)12(19)15-9)11(7)17(4-5-18)23(2,21)22/h6,18H,3-5H2,1-2H3,(H,15,19)(H,16,20) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215295
(CHEMBL248438 | N-(6,7-dichloro-2,3-dioxo-1,2,3,4-t...)Show SMILES CS(=O)(=O)N(CC1CCCO1)c1c(Cl)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12 |w:6.5| Show InChI InChI=1S/C14H15Cl2N3O5S/c1-25(22,23)19(6-7-3-2-4-24-7)12-10(16)8(15)5-9-11(12)18-14(21)13(20)17-9/h5,7H,2-4,6H2,1H3,(H,17,20)(H,18,21) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cGMP-dependent 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50491691
(CHEMBL2387438)Show SMILES COc1ccc(cn1)-c1cc(ccc1OC)C1=Nc2c(nn(CCCO)c2C(=O)NC1)C(C)(C)C |t:18| Show InChI InChI=1S/C26H31N5O4/c1-26(2,3)24-22-23(31(30-24)11-6-12-32)25(33)28-15-19(29-22)16-7-9-20(34-4)18(13-16)17-8-10-21(35-5)27-14-17/h7-10,13-14,32H,6,11-12,15H2,1-5H3,(H,28,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE2 catalytic domain (unknown origin) |
Bioorg Med Chem Lett 23: 3443-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.082 BindingDB Entry DOI: 10.7270/Q2C53PR1 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215291
(CHEMBL248445 | N-(7-chloro-6-methyl-2,3-dioxo-1,2,...)Show SMILES COCCN(c1c(C)c(Cl)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O Show InChI InChI=1S/C13H16ClN3O5S/c1-7-8(14)6-9-10(16-13(19)12(18)15-9)11(7)17(4-5-22-2)23(3,20)21/h6H,4-5H2,1-3H3,(H,15,18)(H,16,19) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A/4B/4C/4D
(Homo sapiens (Human)) | BDBM50491653
(CHEMBL2387136)Show SMILES CCC(CC)c1nn(CCO)c2c1N=C(CNC2=O)c1ccccc1 |c:14| Show InChI InChI=1S/C19H24N4O2/c1-3-13(4-2)16-17-18(23(22-16)10-11-24)19(25)20-12-15(21-17)14-8-6-5-7-9-14/h5-9,13,24H,3-4,10-12H2,1-2H3,(H,20,25) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Inhibition of PDE4 (unknown origin) |
Bioorg Med Chem Lett 23: 3438-42 (2013)
Article DOI: 10.1016/j.bmcl.2013.03.072 BindingDB Entry DOI: 10.7270/Q2MP5665 |
More data for this Ligand-Target Pair | |
Glutamate receptor ionotropic, NMDA 1
(Homo sapiens (Human)) | BDBM50215288
(CHEMBL248444 | N-(6-chloro-7-methyl-2,3-dioxo-1,2,...)Show SMILES COCCN(c1c(Cl)c(C)cc2[nH]c(=O)c(=O)[nH]c12)S(C)(=O)=O Show InChI InChI=1S/C13H16ClN3O5S/c1-7-6-8-10(16-13(19)12(18)15-8)11(9(7)14)17(4-5-22-2)23(3,20)21/h6H,4-5H2,1-3H3,(H,15,18)(H,16,19) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development
Curated by ChEMBL
| Assay Description Antagonist activity at human NMDA NR1 receptor |
Bioorg Med Chem Lett 17: 4599-603 (2007)
Article DOI: 10.1016/j.bmcl.2007.05.083 BindingDB Entry DOI: 10.7270/Q2QR4WTR |
More data for this Ligand-Target Pair | |